Related Experiment Video
Updated: Jun 26, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neurodevelopmental screening for neonates less than 44 weeks gestation in low-income and middle-income countries: a
Benjamin J S Al-Haddad1,2, Elisabeth Olson2, Erin Reardon3
1Department of Pediatrics, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA haddad@umn.edu.
Insights
No single standardized neonatal screening tool effectively identifies neurodevelopmental delays in low-income countries. Further development is needed for rapid, validated assessments to improve outcomes for high-risk newborns.
Area of Science:
- Neonatal neurodevelopmental screening
- Global health
- Developmental pediatrics
Background:
- Neonatal survival improvements increase the risk of neurodevelopmental disability in low- and middle-income countries (LMICs).
- Early identification and intervention are crucial, but standardized screening tools for neonates in LMICs are not well-documented.
Purpose of the Study:
- To systematically review standardized neurodevelopmental assessments used for neonates (before 44 weeks corrected gestational age) in LMICs.
- To identify gaps in current screening practices and tools.
Main Methods:
- Systematic review of seven databases for studies on neonatal neurodevelopmental assessments in LMICs.
- Inclusion criteria focused on standardized assessments, excluding short-term clinical tools.
- Data extraction included country, patient characteristics, assessments used, and study aims.
Main Results:
- 67 studies were included, with most originating from Asian countries (65.7%).
- The most frequently used tools were the Neonatal Behavioural Neurological Assessment (25.4%), General Movements Assessment (22.4%), and Hammersmith Neonatal Neurological Examination/Dubowitz (16.4%).
- Physician/paramedical staff performed screening in only 16.4% of studies, and 92.5% used inpatient recruitment.
Conclusions:
- No single rapid, globally validated neonatal screening tool currently meets all criteria for effective use in LMICs (e.g., identifying intervention targets, high prognostic value, minimal expertise/equipment required).
- Development of such a tool, alongside evidence-based interventions and trained personnel, is essential to improve outcomes for high-risk neonates in LMICs.
Introduction:
With global improvements in neonatal survival, more small and sick newborns in low-income and middle-income countries (LMICs) are at increased risk of neurodevelopmental disability and delay. While there is increased recognition of the importance of early identification of neurodevelopmental differences and timely initiation of therapy, little is known about standardised neonatal neurodevelopmental screening tools in these settings.
Methods:
We performed a systematic review to determine what standardised neurodevelopmental assessments had been used in LMICs for neonates before 44 weeks corrected gestational age and published in the literature. We excluded short-term clinical assessments designed for specific pathologies. We performed the search across seven databases, screened studies for eligibility and inclusion and extracted bibliographic data, country, patient characteristics, assessments and study aims. Results were summarised in tabular and graphical presentation.
Results:
There were 2477 records screened, yielding 67 studies for inclusion. Studies in Asian countries made up 65.7%, while Latin America and Africa made up 19.4% and 16.4%, respectively. Physicians and paramedical staff performed the screening assessments in only 16.4% of studies, and 92.5% of studies used inpatient recruitment. The Neonatal Behavioural Neurological Assessment (25.4%) was the most frequently used screening tool followed by the General Movements Assessment (22.4%), the Hammersmith Neonatal Neurological Examination/Dubowitz (16.4%) and the Neonatal Behavioural Assessment Scale (10.4%).
Conclusions:
We did not identify any one neonatal neurodevelopmental screening assessment that is rapid, globally validated, identifies targets for intervention, has high predictive prognostic value and does not require neonatal or kinesiologic expertise or uncommon equipment. Such an assessment, in concert with evidence-based intervention, therapeutic delivery platforms, established referral pathways and trained personnel would improve functional outcomes for high-risk small and sick neonates in LMICs.
More Related Videos
05:58Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates
Published on: September 6, 2017
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Neurulation
Teratogenicity
Introduction to Developmental Psychology
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Development of Human Microbiota
Development of the Oral Microbiota